Author

Lola Piquer Monsonis

Observed name: L. Piquer Monsonis

Institution: Hospital Universitario Son Espases

Observed institution: Hospital Universitario Son Espases

OpenAlex ID: A5092932829

PB2151 Multidimensional Assessment of Chronic Pain after Switching to Efanesoctocog Alfa in Adults with Haemophilia A: A Real-World Prospective Study

2026 · Emma Serrasolses Alemany, Bernat Galmès Sureda, et al. · Research and Practice in Thrombosis and Haemostasis

PB3336 Five-Year Real-World Evidence of Sustained Bleeding Control and Joint Preservation with Individualized Emicizumab Prophylaxis in Severe Hemophilia A

2026 · Maria Gali Sampalo, Bernat Galmes Sureda, et al. · Research and Practice in Thrombosis and Haemostasis

P62 | Initial Experience With Idecabtagene Vicleucel in Patients With Refractory Multiple Myeloma: Case Series in a Tertiary Care Hospital

2026 · L. Piquer Monsonis, A. Pérez Montaña, et al. · Haematologica

Use of Steroids in Subjects with ITP in Spain: Duration and Toxicity

2024 · Maria Eva Mingot-Castellano, Beatriz Chiclana Rodriguez, et al. · Blood

Investigating the Effectiveness and Safety of Combining Thrombopoietin Receptor Agonist and Immunosuppressant Drugs for Patients with Multirefractory Immune Thrombocytopenia after Second-Line Monotherapy Treatments

2024 · Maria Eva Mingot-Castellano, Patricia Alcalde Mellado, et al. · Blood

P-158 Experience at Son Espases University Hospital with daratumumab, bortezomib, lenalidomide and dexamethasone (D-VRd) as first line treatment in multiple myeloma

2023 · Lola Piquer Monsonis, Maria Galí Sampalo, et al. · Clinical Lymphoma Myeloma & Leukemia

Works count: 6

Citation count:

H-index:

I10-index: